{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:30:37Z","timestamp":1773700237846,"version":"3.50.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771692"],"award-info":[{"award-number":["81771692"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971558"],"award-info":[{"award-number":["81971558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Outbreaks of silicosis have occurred among workers in the artificial stone (AS) industry, and there is currently no effective antifibrosis treatment for silicosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A retrospective cohort study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively analyzed the clinical data of 89 artificial stone-associated silicosis patients treated in Shanghai Pulmonary Hospital (China). Patients who agreed to be administered tetrandrine entered the observation group and those who disagreed entered the control group. Changes in chest HRCT, pulmonary function, and clinical symptoms of patients in two groups were compared pre- and post-treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After treatment for 3\u201312\u2009months, 56.5%\u201365.4% of patients in the observation group showed improvements in HRCT imaging, while there was no improvement in the control group (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.05). Disease progression occurred in 0%\u201317.4% of patients in the observation group after 3\u201312\u2009months of treatment compared with 44.4%\u201392.0% of patients in the control group (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.05). After 3\u2009months of treatment, the forced vital capacity (FVC), forced expiratory volume in 1\u2009s (FEV<jats:sub>1<\/jats:sub>), and diffusing capacity of the lung for carbon monoxide (DLco) in the observation group increased by 136.7\u2009\u00b1\u2009189.2\u2009mL (<jats:italic>p<\/jats:italic>\u2009&amp;lt; 0.05), 124.2\u2009\u00b1\u2009169.9\u2009mL (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.05), and 1.4\u2009\u00b1\u20092.3\u2009mL\/min\/mmHg (<jats:italic>p<\/jats:italic>\u2009&amp;gt;\u20090.05), respectively, while those in the control group decreased (145.8\u2009\u00b1\u2009356.5; 107.5\u2009\u00b1\u2009272.1; 1.9\u2009\u00b1\u20093.8). After 6\u2009months of treatment, FVC, FEV<jats:sub>1<\/jats:sub>, and DLco in the observation group increased by 207.8\u2009\u00b1\u2009372.2\u2009mL (<jats:italic>p<\/jats:italic>\u2009&amp;gt;\u20090.05), 107.8\u2009\u00b1\u2009295.2\u2009mL (<jats:italic>p<\/jats:italic>\u2009&amp;gt;\u20090.05) and 0.7\u2009\u00b1\u20096.0\u2009mL\/min\/mmHg (<jats:italic>p<\/jats:italic>\u2009&amp;gt;\u20090.05), respectively, while those of the control group decreased (383.3\u2009\u00b1\u2009536.7; 215.6\u2009\u00b1\u2009228.9; 1.4\u2009\u00b1\u20091.7). The incidences of clinical symptoms such as cough, expectoration, dyspnea, chest tightness, and chest pain in the observation group were decreased-after treatment (all <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.05), while the incidences of these symptoms increased in the control group, although the change was not statistically significant (all <jats:italic>p<\/jats:italic>\u2009&amp;gt;\u20090.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Tetrandrine can control and delay the progression of AS-associated silicosis fibrosis, with improved chest HRCT imaging and pulmonary function.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1107967","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T06:02:13Z","timestamp":1676613733000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical efficacy of tetrandrine in artificial stone-associated silicosis: A retrospective cohort study"],"prefix":"10.3389","volume":"10","author":[{"given":"Wen-hong","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-hong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-yan","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-lan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/oemed-2017-104428","article-title":"Artificial stone-associated silicosis: a rapidly emerging occupational lung disease","volume":"75","author":"Hoy","year":"2018","journal-title":"Occup Environ Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.arbres.2009.07.008","article-title":"Silicosis: a disease with an active present","volume":"46","author":"Mart\u00ednez","year":"2010","journal-title":"Arch Bronconeumol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.rce.2018.06.006","article-title":"Silicosis: a former occupational disease with new occupational exposure scenarios. Silicosis: una antigua enfermedad profesional con nuevos escenarios de exposici\u00f3n laboral","volume":"219","author":"Pascual Del Pobil","year":"2019","journal-title":"Rev Clin Esp (Barc)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/oemed-2018-105436","article-title":"Artificial stone-associated silicosis in Belgium","volume":"76","author":"Ronsmans","year":"2019","journal-title":"Occup Environ Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"541.1","DOI":"10.1136\/oemed-2018-105028","article-title":"Artificial stone-associated silicosis in the UK","volume":"75","author":"Barber","year":"2018","journal-title":"Occup Environ Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.chest.2020.03.026","article-title":"Artificial stone silicosis: rapid progression following exposure cessation","volume":"158","author":"Le\u00f3n-Jim\u00e9nez","year":"2020","journal-title":"Chest"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"832052","DOI":"10.3389\/fmed.2022.832052","article-title":"Risk factors of silicosis progression: a retrospective cohort study in China","volume":"9","author":"Quan","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"744","DOI":"10.13213\/j.cnki.jeom.2019.19260","article-title":"Investigation of clinical features and working environment of silicosis patients caused by agglomerated quartz stone processing dust","volume":"36","author":"Mao","year":"2019","journal-title":"J Environ Occup Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.phytochem.2016.02.005","article-title":"Tetrandrine\u2013a molecule of wide bioactivity","volume":"125","author":"Bhagya","year":"2016","journal-title":"Phytochemistry"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3892\/etm.2020.8858","article-title":"Clinical efficacy of acetylcysteine combined with tetrandrine tablets on patients with silicosis and its effect on exercise tolerance and pulmonary function","volume":"20","author":"Guo","year":"2020","journal-title":"Exp Ther Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.3892\/etm.2019.7966","article-title":"Clinical efficacy of acetylcysteine combined with tetrandrine tablets in the treatment of silicosis and the effect on serum IL-6 and TNF-\u03b1","volume":"18","author":"Sun","year":"2019","journal-title":"Exp Ther Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3892\/etm.2020.8431","article-title":"Effects of tetrandrine combined with acetylcysteine on exercise tolerance, pulmonary function and serum TNF-\u03b21 and MMP-7 in silicosis patients","volume":"19","author":"Zhang","year":"2020","journal-title":"Exp Ther Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/1754-9485.13015","article-title":"Silicosis in artificial stone workers: spectrum of radiological high-resolution CT chest findings","volume":"64","author":"Jones","year":"2020","journal-title":"J Med Imaging Radiat Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1183\/09031936.05.00034905","article-title":"Standardisation of the single-breath determination of carbon monoxide uptake in the lung","volume":"26","author":"Macintyre","year":"2005","journal-title":"Eur Respir J"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/resp.13744","article-title":"Artificial stone-associated silicosis in China: a prospective comparison with natural stone-associated silicosis","volume":"25","author":"Wu","year":"2020","journal-title":"Respirology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/ACI.0000000000000715","article-title":"Artificial stone silicosis","volume":"21","author":"Hoy","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref18","first-page":"92","article-title":"A preliminary study of the mechanism of silicosis therapy by Tetrandrine","volume":"6","author":"Jiang","year":"1983","journal-title":"Chin J Tuberculosis Respir Dis"},{"key":"ref19","first-page":"243","article-title":"Autopsy and Histochemical analysis: report of a case of silicosis treated with Tetrandrine","volume":"5","author":"Li","year":"1982","journal-title":"Chin J Tuberculosis Respir Dis"},{"key":"ref20","first-page":"129","article-title":"Observation of the therapeutic effect of Tetrandrine on experimental silicosis in rats Chinese","volume":"1","author":"Zou","year":"1983","journal-title":"J Ind Hyg Occup Dis"},{"key":"ref21","first-page":"130","article-title":"Clincal trial and evaluation of treatment for Silocosis","volume":"14","author":"Li","year":"1996","journal-title":"Chin J Ind Hyg Occup Dis"},{"key":"ref22","first-page":"136","article-title":"Clinical observation on the treatment of simple silicosis with Tetrandrine","volume":"1","author":"Lu","year":"1983","journal-title":"Chin J Ind Hyg Occup Dis"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1107967\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T06:02:21Z","timestamp":1676613741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1107967\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":22,"alternative-id":["10.3389\/fmed.2023.1107967"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1107967","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,17]]},"article-number":"1107967"}}